IT1195852B - Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati - Google Patents

Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati

Info

Publication number
IT1195852B
IT1195852B IT48228/86A IT4822886A IT1195852B IT 1195852 B IT1195852 B IT 1195852B IT 48228/86 A IT48228/86 A IT 48228/86A IT 4822886 A IT4822886 A IT 4822886A IT 1195852 B IT1195852 B IT 1195852B
Authority
IT
Italy
Prior art keywords
halotane
carnitine
inhalation
toxic effects
anestytics
Prior art date
Application number
IT48228/86A
Other languages
English (en)
Other versions
IT8648228A0 (it
Inventor
Noris Siliprandi
Guido Scutari
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT48228/86A priority Critical patent/IT1195852B/it
Publication of IT8648228A0 publication Critical patent/IT8648228A0/it
Priority to AT87830246T priority patent/ATE73326T1/de
Priority to EP87830246A priority patent/EP0253777B1/en
Priority to DE8787830246T priority patent/DE3777270D1/de
Priority to ES198787830246T priority patent/ES2033341T3/es
Priority to US07/069,256 priority patent/US4780308A/en
Application granted granted Critical
Publication of IT1195852B publication Critical patent/IT1195852B/it
Priority to GR920400692T priority patent/GR3004333T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT48228/86A 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati IT1195852B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT48228/86A IT1195852B (it) 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati
AT87830246T ATE73326T1 (de) 1986-07-04 1987-07-01 Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika.
EP87830246A EP0253777B1 (en) 1986-07-04 1987-07-01 Use of L-carnitine for the manufacture of a medicament for the treatment of toxic effects induced by the inhalation of halothane and other halogen-containing general anesthetics.
DE8787830246T DE3777270D1 (de) 1986-07-04 1987-07-01 Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika.
ES198787830246T ES2033341T3 (es) 1986-07-04 1987-07-01 Uso de la l-carnitina en el tratamiento de los efectos toxicos inducidos por inhalacion de halotane y otros anestesicos generales conteniendo halogenos.
US07/069,256 US4780308A (en) 1986-07-04 1987-07-02 Use of L-carnitine in the treatment of toxic effects induced by the inhalation of halotane and other halogen-containing general anesthetics
GR920400692T GR3004333T3 (it) 1986-07-04 1992-04-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48228/86A IT1195852B (it) 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati

Publications (2)

Publication Number Publication Date
IT8648228A0 IT8648228A0 (it) 1986-07-04
IT1195852B true IT1195852B (it) 1988-10-27

Family

ID=11265360

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48228/86A IT1195852B (it) 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati

Country Status (7)

Country Link
US (1) US4780308A (it)
EP (1) EP0253777B1 (it)
AT (1) ATE73326T1 (it)
DE (1) DE3777270D1 (it)
ES (1) ES2033341T3 (it)
GR (1) GR3004333T3 (it)
IT (1) IT1195852B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
JPS59222412A (ja) * 1983-06-01 1984-12-14 Earth Chem Corp Ltd 心臓疾患治療薬
JPS60155115A (ja) * 1984-01-24 1985-08-15 Japan Hosupitaru Supply:Kk 血圧上昇剤

Also Published As

Publication number Publication date
US4780308A (en) 1988-10-25
EP0253777A3 (en) 1990-01-31
EP0253777A2 (en) 1988-01-20
IT8648228A0 (it) 1986-07-04
ES2033341T3 (es) 1993-03-16
ATE73326T1 (de) 1992-03-15
DE3777270D1 (de) 1992-04-16
GR3004333T3 (it) 1993-03-31
EP0253777B1 (en) 1992-03-11

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
CA2039197A1 (en) Pharmaceutic Formulation for the Treatment of Alcoholism
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
EP0217206A3 (en) Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
DK232989D0 (da) Antiviralt praeparat
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
FI961169A0 (fi) Kiteinen vedetön mykofenolaattimofetiili ja sen intravenoosivalmiste
CA2179015A1 (en) Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
NO923721D0 (no) 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
IT1195852B (it) Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati
ATE241980T1 (de) Neue inhalationspräparate enthaltend cr 2039 (andolast)
EP0347749A3 (en) Pyrazoloacridone derivatives with anti-tumoral activity
EP0339600A3 (en) Polycyclic amine derivatives useful as cerebrovascular agents
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
SE8903764L (sv) Lung protection agents
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
DE68910010D1 (de) Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin.
EP0335446A3 (en) Agents for treating neoplasms
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
EP0354042A3 (en) Aminobenzoic-acid derivatives to reduce side effects induced by an administration of immuno-suppressant

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970609